May 12, 2023
Bulletin interne de l'Institut Pasteur
• A series of new tools and protocols are now available for your SARS-CoV-2 genome engineering projects.
The COVID-19 Task Force has launched a research program, "PFR-1," for reverse genetics of SARS-CoV-2, coordinated by Florence Larrous and Sandie Munier.
A series of recombinant viruses with mutations in some genes or expressing reporter genes have been obtained and are now available ("In vivo experiments on hamster model: Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants" – G. Dias de Melo, bioRxiv 2022.08.31.50598).
If you are interested and/or have any technical or regulatory questions about PFR-1, please contact:
Technical part: florence.larrous@pasteur.fr ; sandie.munier@pasteur.fr
Dual use: durc@pasteur.fr
• Save the date – Second half-day of discussions on COVID-19 and SARS-CoV-2 organized on Thursday November 9, 2023, from 2 to 5.30pm, in the auditorium of the François Jacob building.
The aim of this scientific event is to review several projects launched by the COVID-19 Task Force (COVID-RP and PFR).
The event is exclusively open to Institut Pasteur scientists based on campus (especially those working on COVID-19 research), with the aim of reporting the latest news on nine research projects launched by the COVID-19 Task Force in 2021.
The format will be as follows:
• 15 mins./project: 10 mins. (aims, results to date and future prospects) followed by 5 mins. for questions
• Two question/answer questions at the end of sessions 1 and 2
• A general discussion followed by conclusions
The event is free but prior registration is required – please email Gladys Elisabeth: gladys.elisabeth@pasteur.fr
To find out more, please contact: mallory.perrin-wolff@pasteur.fr